Your search history is turned on.
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - FilamentHealth_Press Release_MMessingerBoardAppointment.docx FILAMENTHEALTHANNOUNCESAPPOINTMENTOFMICHAELMESSINGERTOITS BOARDOFDIRECTORS Vancouver, British Columbia,March 28, 2024 FilamentHealth Corp. (OTCQB:FLHLF) (Cboe CA:FH) (FSE:7QS) (Filament or the Company), a clinicalstage natural psychedel...
Microsoft Word - FilamentHealth_PressRelease_YearEnd2023.docx FILAMENTHEALTHREPORTSQ4ANDYEAREND2023FINANCIALRESULTS ANDOPERATIONALHIGHLIGHTS Vancouver,BritishColumbia,April2,2024FilamentHealthCorp.(OTCQB:FLHLF)(NEO:FH) (FSE:7QS)(FilamentortheCompany),aclinicalstagenaturalpsychedelicdrugdevelopment company,releasedits...
Date: April 2, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, NGUYEN, Steven, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonabl...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
FH - CFO Certificate for AFS FYE December 31 2023.DOC.pdf Form 52-109F1 Certification of Annual Filings Full Certificate I, Steven Nguyen, Interim Chief Financial Officer of Filament Health Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all do...
FH - CEO Certificate for AFS FYE December 31 2023.DOC.pdf Form 52-109F1 Certification of Annual Filings Full Certificate I, Benjamin Lightburn, Chief Executive Officer of Filament Health Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all docum...
2023-12-31 FH - Annual Information Form - 2024-04-02 FILAMENT HEALTH CORP. ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 DATED APRIL 2, 2024 FILAMENT HEALTH CORP. ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 TABLE OF CONTENTS Introductory Notes 1 Date of Informati...
2023-12-31 FH - YE MD&A - 2024-04-02 Filament Health Corp. Managements Discussion and Analysis For the year ended December 31, 2023 (Expressed in Canadian Dollars) Filament Health Corp. Managements Discussion & Analysis For the year ended December 31, 2023 (Expressed in Canadian Dollars) 2 ...
Microsoft Word - 2023-12-31 FH - YE FS v7 - 2024-04-02 Filament Health Corp. Consolidated Financial Statements For the year ended December 31, 2023 (Expressed in Canadian Dollars) Filament Health Corp. Table of Contents INDEPENDENT AUDITORS REPORT .................................................................................................. 3...
Date: March 19, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION Research institutions in the United States, Canada, Israel, and Belgium, including Johns Hopkins University, will study PEX010, Filaments botanical psilocybin drug candidate Vancouver, British Columbia, March 19, 2024 Filament Health Corp. (OTCQB...